Clin2
NCT07606833Possibly a fitNot yet recruiting

Combination therapy for helicobacter pylori infection

HELICOBACTER PYLORI INFECTIONS

Part of Digestive system, Infections clinical trials.

This trial tests a new medication combined with standard antibiotics and bismuth to treat helicobacter pylori, a bacteria that can cause stomach ulcers. It aims to see if this combination is safe and effective in clearing the infection.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 3
Enrollment
556 people
Ages
18 years to 75 years
Study type
Interventional

Who can take part

  • You are between 18 and 75 years old
  • You have a confirmed helicobacter pylori infection
  • You have not previously been treated for this infection
  • You do not have severe stomach bleeding, ulcers, or other serious health conditions
  • You are not allergic to any of the study medications
  • You are not pregnant or planning to become pregnant during the study

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07576959Recruiting· Phase 3
Bismuth with dual therapy for H. pylori infection treatment

This trial tests whether adding bismuth (a mineral compound) to standard two-drug therapy helps cure H. pylori, a common stomach bacteria that can cause ulcers and inflammation. The goal is to see if this combination works better than dual therapy alone.

Taipei
NCT07750938Not yet recruiting· Phase 4
Better acid control for first-time H. pylori treatment

This study tests a new combination of medicines to treat H. pylori, a stomach infection that can cause ulcers. It aims to see if stronger acid suppression helps the antibiotics work better and clear the infection.

NCT07293910Recruiting· Phase 2
Comparing stomach acid drugs for clearing H. pylori infection

This trial tests different combinations of stomach acid-reducing drugs, vitamin D or probiotics, to see which works best for clearing an H. pylori infection. H. pylori is a common stomach bacteria that can cause ulcers or stomach discomfort.

Shibīn al Kawm
NCT06734260Recruiting· Phase 3
Optimizing a two-drug therapy for H. pylori infection

This trial tests a two-drug combination (keverprazan and amoxicillin) to see if it works better for treating H. pylori, a bacteria that can cause stomach problems. It is for people who have had H. pylori before and need treatment again.

Guangzhou, Guangdong
NCT07537634Recruiting· Phase 4
New stomach acid medicine versus standard treatment for H. pylori infection

This trial compares two different antibiotic combinations to treat H. pylori, a common stomach bacteria that causes indigestion and ulcers. One uses a newer acid-blocking medicine (vonoprazan) and the other uses a standard one (esomeprazole), both paired with antibiotics.

Dhaka
NCT07115173Not yet recruiting· Phase 4
Triple therapy for h. pylori infection

This study tests a three-drug combination (called triple therapy) to get rid of H. pylori, a bacteria that can cause stomach problems like ulcers and inflammation. If you have H. pylori and one of the listed stomach conditions, this treatment might help clear the infection.

Hear when a new HELICOBACTER PYLORI INFECTIONS trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.